Pages that link to "Q28571807"
Jump to navigation
Jump to search
The following pages link to Evidence that IL-6-type cytokine signaling in cardiomyocytes is inhibited by oxidative stress: parthenolide targets JAK1 activation by generating ROS (Q28571807):
Displaying 28 items.
- Prevention of colitis-associated cancer: natural compounds that target the IL-6 soluble receptor (Q27022976) (← links)
- Mitochondria and reactive oxygen species: physiology and pathophysiology (Q28397259) (← links)
- Parthenolide-Induced Cytotoxicity in H9c2 Cardiomyoblasts Involves Oxidative Stress (Q28468705) (← links)
- Acyloxy nitroso compounds inhibit LIF signaling in endothelial cells and cardiac myocytes: evidence that STAT3 signaling is redox-sensitive (Q28482269) (← links)
- RIP3 overexpression sensitizes human breast cancer cells to parthenolide in vitro via intracellular ROS accumulation (Q33869714) (← links)
- Parthenolide induces caspase-independent and AIF-mediated cell death in human osteosarcoma and melanoma cells. (Q34300445) (← links)
- Manganese modulation of MAPK pathways: effects on upstream mitogen activated protein kinase kinases and mitogen activated kinase phosphatase-1 in microglial cells (Q34367745) (← links)
- Dynamic Redox Regulation of IL-4 Signaling (Q35839957) (← links)
- Identification of a redox-sensitive switch within the JAK2 catalytic domain (Q35869293) (← links)
- Depletion of cellular glutathione modulates LIF-induced JAK1-STAT3 signaling in cardiac myocytes (Q36392857) (← links)
- Role of gp130-mediated signalling pathways in the heart and its impact on potential therapeutic aspects (Q36497007) (← links)
- Differential STAT3 signaling in the heart: Impact of concurrent signals and oxidative stress (Q36895459) (← links)
- Genome-Wide Transcriptional Analysis Reveals the Protection against Hypoxia-Induced Oxidative Injury in the Intestine of Tibetans via the Inhibition of GRB2/EGFR/PTPN11 Pathways. (Q37195313) (← links)
- Identify potential drugs for cardiovascular diseases caused by stress-induced genes in vascular smooth muscle cells. (Q37302839) (← links)
- Redox regulation of Janus kinase: The elephant in the room (Q37421820) (← links)
- JAK redux: a second look at the regulation and role of JAKs in the heart (Q37430884) (← links)
- Parthenolide generates reactive oxygen species and autophagy in MDA-MB231 cells. A soluble parthenolide analogue inhibits tumour growth and metastasis in a xenograft model of breast cancer (Q37577470) (← links)
- Loss of STAT3 in mouse embryonic fibroblasts reveals its Janus-like actions on mitochondrial function and cell viability (Q37606077) (← links)
- Tuberatolide B Suppresses Cancer Progression by Promoting ROS-Mediated Inhibition of STAT3 Signaling (Q37721791) (← links)
- Genetic Interactions of STAT3 and Anticancer Drug Development (Q38198930) (← links)
- Targeting Thioredoxin Reductase by Parthenolide Contributes to Inducing Apoptosis of HeLa Cells. (Q41098427) (← links)
- Modulation of Gene Expression and Tumor Cell Growth by Redox Modification of STAT3 (Q42921055) (← links)
- Amyloid-beta causes memory impairment by disturbing the JAK2/STAT3 axis in hippocampal neurons. (Q46350343) (← links)
- Parthenolide sensitizes hepatocellular carcinoma cells to TRAIL by inducing the expression of death receptors through inhibition of STAT3 activation. (Q54603551) (← links)
- From Oxidative Stress Damage to Pathways, Networks, and Autophagy via MicroRNAs. (Q55003266) (← links)
- Nucleus, Mitochondrion, or Reticulum? STAT3 à La Carte (Q58722853) (← links)
- Transcriptional profiling in the livers of rats after hypobaric hypoxia exposure (Q64064744) (← links)
- Parthenolide Inhibits STAT3 Signaling by Covalently Targeting Janus Kinases (Q89157942) (← links)